Dr Reddy’s bets big on biosimilars, eyes regulated markets – Economic Times

The biosimilars portfolio in India grew by 33 per cent during the fiscal. Biosimilars are approved similar versions of innovator bio-pharmaceutical products following patent and exclusivity expiry of the innovator product. At present …